Most Recent
$28M settlement in Arnold Bloch Leibler class action to get court’s OK
A judge will approve a $28 million settlement resolving a class action against Arnold Bloch Leibler over advice the law firm gave to Slater & Gordon ahead of a disastrous acquisition. A 28 per cent commission for the case's funder will also get the court's nod.
Careers Australia liquidator can pursue overseas directors on evidence of insolvent trading
The liquidator of collapsed vocational education provider Careers Australia can serve its lawsuit on two of the company’s former directors now living overseas, after a judge found a prima facie case of insolvent trading and breaches of directors duties had been made out.
Deloitte foreshadows new privilege battle in Hastie class action
Another fight over privilege may be on the cards in a shareholder class action over the collapse of the Hastie Group, with Deloitte flagging its partners may claim privilege over certain parts of the accounting giant's evidence.
ASIC drops most claims against Rio Tinto over $5.8B acquisition
The Australian Securities and Investments Commission has dropped all but one claim against Rio Tinto in a four-year-long case over disclosures related to its troubled $5.8 billion acquisition of a Mozambique coal mining business and abandoned all claims against the mining giant's former CEO and CFO.
Landmark class closure judgments ‘plainly wrong,’ appeals court told
Judgments shooting down a class closure order and nixing notice of a possible class closure order were "plainly wrong" and "infected" by faulty reasoning, the Full Federal Court has heard.
GetSwift says stock price drop didn’t prove ‘materiality’ of ASX statements
Logistics company GetSwift will argue on appeal that a judge who found the company took a "PR-driven approach" to ASX statements was wrong in his assessment of whether those statements contained material omissions.
Mesoblast faces fresh class action investigation over stem cell therapy claims
A second class action investigation against regenerative medicine company Mesoblast is underway, this one looking at claim it misled shareholders about the potential application of a developmental stem cell product to treat terminally-ill children.
Wotif founder ordered to pay $15M in aquaculture share dispute
Philanthropist and Wotif founder Graeme Wood will have to pay more than $15 million after the Victoria Supreme Court found one of his companies had breached an agreement to act as guarantor for the $73 million sale of a Queensland aquaculture business.
Funder may walk if 40% group costs order rejected in Arrium class action
A funder that's helping foot the bill in a class action against Arrium's former directors and KPMG may withdraw support if the law firm that's running it is not granted an order awarding it 40 per cent of any award or settlement.
Virgin Australia may face class action over 2019 prospectus
Virgin Australia is facing a shareholder class action investigation over representations made in a 2019 prospectus for a capital raising to fund its $700 million acquisition of the Velocity loyalty program, issued six months before the airline filed for administration.